A Comparison of 2 Standard Doses of Bevacizumab in Combination With Chemotherapy in Epithelial Ovarian Cancer

NCT04787289 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

244

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer
Platinum-resistant Ovarian Cancer

Interventions

DRUG: Bevacizumab

Sponsor

British Columbia Cancer Agency